Dianyuan Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Dianyuan Li has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
Dongsheng He
Department of Cardiovascular Surgery The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital Suzhou China
3 shared publicationsZhipeng Ren
Department of Cardiovascular Surgery The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital Suzhou China
3 shared publicationsZiqiang Dai
Department of Cardiovascular Surgery The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital Suzhou China
3 shared publicationsGen Zhang
Department of Cardiovascular Surgery The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital Suzhou China
2 shared publications- Guanzheng Cui
Department of Cardiovascular Surgery The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital Suzhou China
2 shared publications Huan Wang
Department of Cardiovascular Surgery, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, 215008 Suzhou, Jiangsu, China
2 shared publications
Latest Publications
- Open Access
- 11 May 2026
- Published by Wiley in Xenotransplantation
- Vol. 33 (3) , e70137
Early Experimental Report of the First 8‐Gene‐Edited Pig‐to‐Rhesus Macaque Cardiac Xenotransplantation in China
Objectives: This study aimed to investigate the functional recovery of an 8‐gene‐edited pig heart after orthotopic xenotransplantation, the characteristics of the recipient's immune responses, and the efficacy of postoperative complication management to provide comprehensive experimental evidence for the clinical translation of xenogeneic cardiac transplantation technology. Methods: On December 27, 2025, an orthotopic heart was xenotransplanted from an 8‐gene‐edited pig to a rhesus macaque using the biatrial anastomosis technique. Postoperatively, comprehensive vital sign monitoring, immunosuppressive therapy, and complication interventions were implemented. Donor organ cardiac function, recipient immune indicators, and survival status were evaluated within 30 days after transplantation. Results: The recipient macaque survived for more than 30 days postoperatively. The cardiac function of the donor heart gradually stabilized, with the ejection fraction increasing from 58% in the early postoperative phase to 66%. No hyperacute immune rejection occurred. Postoperative complications, including infection, pleural effusion, and blood pressure fluctuations, were effectively controlled with symptomatic treatment. Conclusions: An 8‐gene‐edited pig heart demonstrates good biocompatibility in xenogeneic cardiac transplantation. Standardized surgical procedures, precise immunosuppressive regimens, and comprehensive postoperative care can effectively ensure desirable transplantation outcomes. This study offers an important technical reference for clinical xenogeneic cardiac transplantation.
- 11 May 2026
- Published by Wiley in Xenotransplantation
- Vol. 33 (3) , e70137
Open AccessEarly Experimental Report of the First 8‐Gene‐Edited Pig‐to‐Rhesus Macaque Cardiac Xenotransplantation in China
Objectives: This study aimed to investigate the functional recovery of an 8‐gene‐edited pig heart after orthotopic xenotransplantation, the characteristics of the recipient's immune responses, and the efficacy of postoperative complication management to provide comprehensive experimental evidence for the clinical translation of xenogeneic cardiac transplantation technology. Methods: On December 27, 2025, an orthotopic heart was xenotransplanted from an 8‐gene‐edited pig to a rhesus macaque using the biatrial anastomosis technique. Postoperatively, comprehensive vital sign monitoring, immunosuppressive therapy, and complication interventions were implemented. Donor organ cardiac function, recipient immune indicators, and survival status were evaluated within 30 days after transplantation. Results: The recipient macaque survived for more than 30 days postoperatively. The cardiac function of the donor heart gradually stabilized, with the ejection fraction increasing from 58% in the early postoperative phase to 66%. No hyperacute immune rejection occurred. Postoperative complications, including infection, pleural effusion, and blood pressure fluctuations, were effectively controlled with symptomatic treatment. Conclusions: An 8‐gene‐edited pig heart demonstrates good biocompatibility in xenogeneic cardiac transplantation. Standardized surgical procedures, precise immunosuppressive regimens, and comprehensive postoperative care can effectively ensure desirable transplantation outcomes. This study offers an important technical reference for clinical xenogeneic cardiac transplantation.
- 6 May 2026
- Published by Wiley in Xenotransplantation
- Vol. 33 (3) , e70141
Methodological Approaches to Improve the Robustness of Bibliometric Studies in Xenotransplantation
- 6 May 2026
- Published by Wiley in Xenotransplantation
- Vol. 33 (3) , e70141
Methodological Approaches to Improve the Robustness of Bibliometric Studies in Xenotransplantation
- 29 August 2025
- Published by Springer Nature in Hypertension Research
- Vol. 48 (11) , 2969-2978
Deciphering genetic associations with blood pressure in peripheral blood mononuclear cells through single-cell transcriptomic profiling
Functional genes within genomic loci associated with blood pressure (BP) identified by genome-wide association studies (GWASs) are cell type-specific. This study aims to identify such genes in immune cells by employing single-cell transcriptomic analysis in peripheral blood mononuclear cells (PBMCs). By integration of single-cell transcriptomic sequencing data with GWAS (1 million individuals) findings using the summary data–based Mendelian randomization (SMR) method, we identified candidate BP-associated genes across diverse immune cell subsets. We performed single-cell RNA sequencing on PBMCs (111,694 cells) from 10 individuals (three hypertensive, three pre-hypertensive and four normotensive), identifying gene expression in distinct cell types associated with hypertension. Finally, publicly available data from eight individuals were utilized for validation (28,919 cells). Single-cell expression quantitative trait locus analysis revealed that the BP-associated SNPs were associated with expression levels of 353 genes across 14 distinct immune cell types. The single-cell SMR analysis identified 566 significant associations between expression levels of 159 genes and BP. The analysis of data from hypertensive and normotensive individuals unveils 99 differential expression genes across various immune cell types, with ERAP2 exhibiting significant dysregulation in CD8+ T cells and natural killer cells. These findings were corroborated through validation analyses. Our study contributes to a comprehensive understanding of the intricate relationships between genetic variation, immune cell-specific gene expression, and BP. We demonstrate a compelling association between ERAP2 expression levels in CD8+ T cells and natural killer cells and BP.
- 29 August 2025
- Published by Springer Nature in Hypertension Research
- Vol. 48 (11) , 2969-2978
Deciphering genetic associations with blood pressure in peripheral blood mononuclear cells through single-cell transcriptomic profiling
Functional genes within genomic loci associated with blood pressure (BP) identified by genome-wide association studies (GWASs) are cell type-specific. This study aims to identify such genes in immune cells by employing single-cell transcriptomic analysis in peripheral blood mononuclear cells (PBMCs). By integration of single-cell transcriptomic sequencing data with GWAS (1 million individuals) findings using the summary data–based Mendelian randomization (SMR) method, we identified candidate BP-associated genes across diverse immune cell subsets. We performed single-cell RNA sequencing on PBMCs (111,694 cells) from 10 individuals (three hypertensive, three pre-hypertensive and four normotensive), identifying gene expression in distinct cell types associated with hypertension. Finally, publicly available data from eight individuals were utilized for validation (28,919 cells). Single-cell expression quantitative trait locus analysis revealed that the BP-associated SNPs were associated with expression levels of 353 genes across 14 distinct immune cell types. The single-cell SMR analysis identified 566 significant associations between expression levels of 159 genes and BP. The analysis of data from hypertensive and normotensive individuals unveils 99 differential expression genes across various immune cell types, with ERAP2 exhibiting significant dysregulation in CD8+ T cells and natural killer cells. These findings were corroborated through validation analyses. Our study contributes to a comprehensive understanding of the intricate relationships between genetic variation, immune cell-specific gene expression, and BP. We demonstrate a compelling association between ERAP2 expression levels in CD8+ T cells and natural killer cells and BP.
- Open Access
- 19 March 2025
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 26 (3) , 26697
Advances and Prospects in Using Induced Pluripotent Stem Cells for 3D Bioprinting in Cardiac Tissue Engineering
Background: Cardiovascular diseases remain one of the leading causes of death worldwide. Given the limited self-repair capacity of cardiac tissue, cardiac tissue engineering (CTE) aims to develop strategies and materials for repairing or replacing damaged cardiac tissue by combining biology, medicine, and engineering. Indeed, CTE has made significant strides since the discovery of induced pluripotent stem cells (iPSCs) in 2006, including creating cardiac patches, organoids, and chip models derived from iPSCs, thus offering new strategies for treating cardiac diseases. Methods: A systematic search for relevant literature published between 2003 and 2024 was conducted in the PubMed and Web of Science databases using “Cardiac Tissue Engineering”, “3D Bioprinting”, “Scaffold in Tissue Engineering”, “Induced Pluripotent Stem Cells”, and “iPSCs” as keywords. Results: This systematic search using the abovementioned keywords identified relevant articles for inclusion in this review. The resulting literature indicated that CTE can offer innovative solutions for treating cardiac diseases when integrated with three-dimensional (3D) bioprinting and iPSC technology. Conclusions: Despite notable advances in the field of CTE, multiple challenges remain relating to 3D-bioprinted cardiac tissues. These include maintaining long-term cell viability, achieving precise cell distribution, tissue vascularization, material selection, and cost-effectiveness. Therefore, further research is needed to optimize printing techniques, develop more advanced bio-inks, explore larger-scale tissue constructs, and ensure the biosafety and functional fidelity of engineered cardiac tissues. Subsequently, future research efforts should focus on these areas to facilitate the clinical translation of CTE. Moreover, additional long-term animal models and preclinical studies should be conducted to ensure the biosafety and functionality of engineered cardiac tissues, thereby creating novel possibilities for treating patients with heart diseases.
- 19 March 2025
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 26 (3) , 26697
Open AccessAdvances and Prospects in Using Induced Pluripotent Stem Cells for 3D Bioprinting in Cardiac Tissue Engineering
Background: Cardiovascular diseases remain one of the leading causes of death worldwide. Given the limited self-repair capacity of cardiac tissue, cardiac tissue engineering (CTE) aims to develop strategies and materials for repairing or replacing damaged cardiac tissue by combining biology, medicine, and engineering. Indeed, CTE has made significant strides since the discovery of induced pluripotent stem cells (iPSCs) in 2006, including creating cardiac patches, organoids, and chip models derived from iPSCs, thus offering new strategies for treating cardiac diseases. Methods: A systematic search for relevant literature published between 2003 and 2024 was conducted in the PubMed and Web of Science databases using “Cardiac Tissue Engineering”, “3D Bioprinting”, “Scaffold in Tissue Engineering”, “Induced Pluripotent Stem Cells”, and “iPSCs” as keywords. Results: This systematic search using the abovementioned keywords identified relevant articles for inclusion in this review. The resulting literature indicated that CTE can offer innovative solutions for treating cardiac diseases when integrated with three-dimensional (3D) bioprinting and iPSC technology. Conclusions: Despite notable advances in the field of CTE, multiple challenges remain relating to 3D-bioprinted cardiac tissues. These include maintaining long-term cell viability, achieving precise cell distribution, tissue vascularization, material selection, and cost-effectiveness. Therefore, further research is needed to optimize printing techniques, develop more advanced bio-inks, explore larger-scale tissue constructs, and ensure the biosafety and functional fidelity of engineered cardiac tissues. Subsequently, future research efforts should focus on these areas to facilitate the clinical translation of CTE. Moreover, additional long-term animal models and preclinical studies should be conducted to ensure the biosafety and functionality of engineered cardiac tissues, thereby creating novel possibilities for treating patients with heart diseases.
- Open Access
- 11 March 2024
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 25 (3) , 101
Application of Three-Dimensional Printing Technology in the Perioperative Management of Cardiac Tumours: A Review and Analysis
Background: Multimodal imaging plays a crucial role in evaluating suspected cardiac tumours. In recent years, three-dimensional (3D) printing technology has continued to advance such that image-based 3D-printed models have been incorporated into the auxiliary diagnosis and treatment of cardiac tumour diseases. The purpose of this review is to analyze the existing literature on the application of 3D printing in cardiac tumour surgery to examine the current status of the application of this technology. Methods: By searching PubMed, Cochrane, Scopus and Google Scholar, as well as other resource databases, a completed review of the available literature was performed. Effect sizes from published studies were investigated, and results are presented concerning the use of 3D surgical planning in the management of cardiac tumours. Results: According to the reviewed literature, our study comes to the point that 3D printing is a valuable technique for planning surgery for cardiac tumours. As shown in the review report, Mucinous and sarcomatous tumours are the most commonly used tumours for 3D printing, magnetic resonance imaging (MRI) and computed tomography (CT) are the most commonly used technologies for preparing 3D printing models, the main printing technology is stereolithography, and the most used 3D modeling software is Mimics. The printing time and cost required for 3D printing are affected by factors such as the size of the type, complexity, the printed material and the 3D printing technology used. The reported research shows that 3D printing can understand the anatomy of complex tumour cases, virtual surgical simulation, as well as facilitate doctor-patient communication and clinical teaching. Conclusions: These results show that the development of 3D printing technology has brought more accurate and safe perioperative treatment options for patients with cardiac tumours. Therefore, 3D printing technology is expected to become a routine clinical diagnosis and treatment tool for cardiac tumours.
- 11 March 2024
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 25 (3) , 101
Open AccessApplication of Three-Dimensional Printing Technology in the Perioperative Management of Cardiac Tumours: A Review and Analysis
Background: Multimodal imaging plays a crucial role in evaluating suspected cardiac tumours. In recent years, three-dimensional (3D) printing technology has continued to advance such that image-based 3D-printed models have been incorporated into the auxiliary diagnosis and treatment of cardiac tumour diseases. The purpose of this review is to analyze the existing literature on the application of 3D printing in cardiac tumour surgery to examine the current status of the application of this technology. Methods: By searching PubMed, Cochrane, Scopus and Google Scholar, as well as other resource databases, a completed review of the available literature was performed. Effect sizes from published studies were investigated, and results are presented concerning the use of 3D surgical planning in the management of cardiac tumours. Results: According to the reviewed literature, our study comes to the point that 3D printing is a valuable technique for planning surgery for cardiac tumours. As shown in the review report, Mucinous and sarcomatous tumours are the most commonly used tumours for 3D printing, magnetic resonance imaging (MRI) and computed tomography (CT) are the most commonly used technologies for preparing 3D printing models, the main printing technology is stereolithography, and the most used 3D modeling software is Mimics. The printing time and cost required for 3D printing are affected by factors such as the size of the type, complexity, the printed material and the 3D printing technology used. The reported research shows that 3D printing can understand the anatomy of complex tumour cases, virtual surgical simulation, as well as facilitate doctor-patient communication and clinical teaching. Conclusions: These results show that the development of 3D printing technology has brought more accurate and safe perioperative treatment options for patients with cardiac tumours. Therefore, 3D printing technology is expected to become a routine clinical diagnosis and treatment tool for cardiac tumours.
- Open Access
- 22 September 2023
- Published by Springer Nature in Research Square
A 3D-simulation hemodynamic study of the correlation between aortic arch morphology and aortic dissection
Background Reverse tearing and the correlation between aortic arch morphology and aortic dissection were studied with a 3D simulation hemodynamic technique. Methods From 2018 to 2023, 140 patients with aortic dissection admitted to Suzhou Hospital affiliated with Nanjing Medical University and Guangyuan First People's Hospital (age 56.5 ± 12.0 years; 52 female) and 143 healthy controls (age 53.1 ± 11.8 years; 50 female) underwent CTA examination of the whole thoracic and abdominal aorta; the diameter of the three branches of the aortic arch, the angle of the branches, the distance of the branches and the type of the aortic arch were recorded and analyzed. By adjusting the parameter values of risk factors, the morphology of the aortic arch and its branches was simulated, and the regional differences in blood flow velocity and shear force in the 3D simulation experiment were used to evaluate the hemodynamics of the aortic arch. Results Compared with healthy controls, patients with aortic dissection had an angle of the left subclavian artery (OR = 0.841, 95% CI = 0.752–0.942, P = 0.003). The length of the ascending aorta (OR = 0.935, 95% CI = 0.885–0.998, P = 0.017). The bifurcation of the LSA in patients with aortic dissection is the position where WSS in the aortic arch is the highest (compared with other parts of the aortic arch). Compared with patients with nonaortic dissection, the left subclavian artery angle WSS significantly differed. The location of the damaged dissection was categorized as type 1 (Z3) and type 2 (Z2 + Z3). The comparative analysis of the data on the arch in the two groups indicated that the left subclavian angle (P < 0.05) was an independent risk factor. The maximum shear force of the aortic arch was at the LSA bifurcation, and the WSS mean of type 1 and type 2 (10.48 ± 3.09 vs. 21.57 ± 7.31 Pa, p = 0.0001). The LPD of type 1 and type 2 (2.53 ± 2.14 vs. 13.83 ± 8.87 Pa, p = 0.0001). Conclusion The angle of the left subclavian artery and the length of the ascending aorta are independent risk factors for the formation of aortic dissection. Aortic dissection patients receive the greatest shear pressure at the bifurcation of the left subclavian artery and aorta, which is the common location of dissection. The small angle of the left subclavian artery is an independent risk factor for dissection avulsion.
- 22 September 2023
- Published by Springer Nature in Research Square
Open AccessA 3D-simulation hemodynamic study of the correlation between aortic arch morphology and aortic dissection
Background Reverse tearing and the correlation between aortic arch morphology and aortic dissection were studied with a 3D simulation hemodynamic technique. Methods From 2018 to 2023, 140 patients with aortic dissection admitted to Suzhou Hospital affiliated with Nanjing Medical University and Guangyuan First People's Hospital (age 56.5 ± 12.0 years; 52 female) and 143 healthy controls (age 53.1 ± 11.8 years; 50 female) underwent CTA examination of the whole thoracic and abdominal aorta; the diameter of the three branches of the aortic arch, the angle of the branches, the distance of the branches and the type of the aortic arch were recorded and analyzed. By adjusting the parameter values of risk factors, the morphology of the aortic arch and its branches was simulated, and the regional differences in blood flow velocity and shear force in the 3D simulation experiment were used to evaluate the hemodynamics of the aortic arch. Results Compared with healthy controls, patients with aortic dissection had an angle of the left subclavian artery (OR = 0.841, 95% CI = 0.752–0.942, P = 0.003). The length of the ascending aorta (OR = 0.935, 95% CI = 0.885–0.998, P = 0.017). The bifurcation of the LSA in patients with aortic dissection is the position where WSS in the aortic arch is the highest (compared with other parts of the aortic arch). Compared with patients with nonaortic dissection, the left subclavian artery angle WSS significantly differed. The location of the damaged dissection was categorized as type 1 (Z3) and type 2 (Z2 + Z3). The comparative analysis of the data on the arch in the two groups indicated that the left subclavian angle (P < 0.05) was an independent risk factor. The maximum shear force of the aortic arch was at the LSA bifurcation, and the WSS mean of type 1 and type 2 (10.48 ± 3.09 vs. 21.57 ± 7.31 Pa, p = 0.0001). The LPD of type 1 and type 2 (2.53 ± 2.14 vs. 13.83 ± 8.87 Pa, p = 0.0001). Conclusion The angle of the left subclavian artery and the length of the ascending aorta are independent risk factors for the formation of aortic dissection. Aortic dissection patients receive the greatest shear pressure at the bifurcation of the left subclavian artery and aorta, which is the common location of dissection. The small angle of the left subclavian artery is an independent risk factor for dissection avulsion.
- 6 September 2023
- Published by IMR Press in The Heart Surgery Forum
- Vol. 26 (5) , E441-E448
A Rare Case of an Adult Pregnant Patient with the Left Coronary Artery Originating from the Pulmonary Artery: Successful Management and Healthy Maternal-Fetal Outcome
An anomalous left coronary artery originating from the pulmonary artery (ALCAPA) refers to the abnormal origin of the left coronary artery either from the main pulmonary artery, pulmonary artery sinus, or the left and right pulmonary arteries, with the main pulmonary artery or pulmonary artery sinus being the most common sites. If not diagnosed and treated promptly, this condition can result in death within the first year of life in 90% of patients. Asymptomatic children can survive into adulthood, but they are at a high risk of sudden death. In this article, we report a case of a 24-year-old pregnant woman who was diagnosed with ALCAPA during prenatal examination. The pregnancy was successfully maintained until 36 weeks, after which a cesarean section was performed. The patient was then admitted to the cardiac surgery department to improve cardiac function, and six weeks later, a successful left coronary artery transplantation was performed. The patient was discharged and followed up for three months, during which her condition remained stable.
- 6 September 2023
- Published by IMR Press in The Heart Surgery Forum
- Vol. 26 (5) , E441-E448
A Rare Case of an Adult Pregnant Patient with the Left Coronary Artery Originating from the Pulmonary Artery: Successful Management and Healthy Maternal-Fetal Outcome
An anomalous left coronary artery originating from the pulmonary artery (ALCAPA) refers to the abnormal origin of the left coronary artery either from the main pulmonary artery, pulmonary artery sinus, or the left and right pulmonary arteries, with the main pulmonary artery or pulmonary artery sinus being the most common sites. If not diagnosed and treated promptly, this condition can result in death within the first year of life in 90% of patients. Asymptomatic children can survive into adulthood, but they are at a high risk of sudden death. In this article, we report a case of a 24-year-old pregnant woman who was diagnosed with ALCAPA during prenatal examination. The pregnancy was successfully maintained until 36 weeks, after which a cesarean section was performed. The patient was then admitted to the cardiac surgery department to improve cardiac function, and six weeks later, a successful left coronary artery transplantation was performed. The patient was discharged and followed up for three months, during which her condition remained stable.
- 1 November 2016
- Published by Elsevier in International Journal of Cardiology
- Vol. 223, 625-629
Repair of anomalous coronary artery from the pulmonary artery: A-signal center 20-year experience
- 1 November 2016
- Published by Elsevier in International Journal of Cardiology
- Vol. 223, 625-629
Repair of anomalous coronary artery from the pulmonary artery: A-signal center 20-year experience